TC
Tyndall Capital Partners L P
Long-term holder
Total reported value
—
Reporting period: 2026-03-31 · Number of holdings: 1
TYNDALL CAPITAL PARTNERS L P disclosed 1 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of — and a quarterly turnover rate of 0.0%.
Personality snowflake
- Concentration
- 0
- Portfolio Stability
- 0
- Momentum/Contrarian
- 50
- Sector conviction
- 0
- Diversification
- 2
- Sizing Uniformity
- —
Recent moves
Unchanged 000000000
$0.0
Holdings Map
Top 10 holdings by weight
Full holdings list this quarter
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | Stock-Other | — | — | — |
Reported value over time
Sector allocation
Not enough sector-mapped data yet
Sector allocation over time
Quarterly history
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 1 | — | 0 | |
| 2025-12-31 | 1 | — | 0 | |
| 2025-09-30 | 1 | — | 100 | |
| 2025-06-30 | 1 | $451.6K | 0 | |
| 2025-03-31 | 1 | $411.9K | 100 | |
| 2024-12-31 | 1 | $530.6K | 0 | |
| 2024-09-30 | 1 | $426.8K | 0 | |
| 2024-06-30 | 1 | $379.0K | 0 | |
| 2024-03-31 | 1 | $527.3K | 0 | |
| 2023-12-31 | 1 | $550.8K | 0 | |
| 2023-09-30 | 1 | $505.2K | 0 | |
| 2023-06-30 | 1 | — | 0 | |
| 2023-03-31 | 1 | — | 0 | |
| 2022-12-31 | 1 | — | 0 | |
| 2022-09-30 | 1 | — | 0 | |
| 2022-06-30 | 1 | — | 0 | |
| 2022-03-31 | 1 | — | 0 | |
| 2021-12-31 | 1 | — | 0 | |
| 2021-09-30 | 1 | — | 0 | |
| 2021-06-30 | 1 | — | 0 | |
| 2021-03-31 | 1 | — | 0 | |
| 2020-12-31 | 1 | — | 0 | |
| 2020-09-30 | 1 | — | 0 | |
| 2020-06-30 | 1 | — | 0 | |
| 2020-03-31 | 1 | — | 100 | |
| 2019-12-31 | 2 | $2.3M | 26 | 1MMAC268232V |
| 2019-09-30 | 3 | $2.7M | 58 | |
| 2019-06-30 | 3 | $4.9M | 13 | |
| 2019-03-31 | 3 | $5.1M | 35 | |
| 2018-12-31 | 3 | $3.6M | 76 | |
| 2018-09-30 | 3 | $7.9M | 100 | |
| 2018-06-30 | 3 | $6.9M | 63 | |
| 2018-03-31 | 3 | $3.8M | 15 | |
| 2017-12-31 | 3 | $3.5M | 82 | |
| 2017-09-30 | 4 | $7.8M | 11 | |
| 2017-06-30 | 4 | $8.4M | 89 | |
| 2017-03-31 | 3 | $3.5M | 24 | |
| 2016-12-31 | 3 | $2.9M | 66 | |
| 2016-09-30 | 2 | $1.8M | 100 | 168232V268232V |
| 2016-06-30 | 1 | — | 0 | |
| 2016-03-31 | 1 | — | 0 | |
| 2015-12-31 | 1 | — | 0 | |
| 2015-09-30 | 1 | — | 0 | |
| 2015-06-30 | 1 | — | 0 | |
| 2015-03-31 | 1 | — | 0 | |
| 2014-12-31 | 1 | — | 0 | |
| 2014-09-30 | 1 | — | 0 | |
| 2014-06-30 | 1 | — | 0 | |
| 2014-03-31 | 1 | — | 0 | |
| 2013-12-31 | 1 | — | 0 | |
| 2013-09-30 | 1 | — | 0 | |
| 2013-06-30 | 1 | — | 0 |
Holding changes this quarter
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Ikena Oncology INC | — | — | Unchanged |
FAQ
What is Tyndall Capital Partners L P and what type of investor is it?
Tyndall Capital Partners L P is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2026-03-31), the firm manages a tracked equity portfolio valued at approximately —, spread across 1 disclosed positions.
What are Tyndall Capital Partners L P's largest equity positions?
Based on the latest 13F filing, Tyndall Capital Partners L P's top holdings by market value are:
1. Ikena Oncology INC — $0.0
What changes did Tyndall Capital Partners L P make in its most recent portfolio filing?
No notable portfolio changes were recorded for Tyndall Capital Partners L P in the most recent quarter. Holdings appear to have remained relatively stable.
What sectors does Tyndall Capital Partners L P focus on?
Sector breakdown data is not yet available for Tyndall Capital Partners L P. Check back after the next 13F processing cycle.